Cardinal Health Inc
NYSE:CAH
Relative Value
The Relative Value of one CAH stock under the Base Case scenario is 353.262 USD. Compared to the current market price of 103.135 USD, Cardinal Health Inc is Undervalued by 71%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
CAH Competitors Multiples
Cardinal Health Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Cardinal Health Inc
NYSE:CAH
|
25.2B USD | 0.1 | 39.4 | 8.8 | 11.9 | ||
US |
Mckesson Corp
NYSE:MCK
|
70.4B USD | 0.2 | 23.5 | 16.3 | 19 | ||
US |
Cencora Inc
NYSE:COR
|
47.6B USD | 0.2 | 25.5 | 13 | 18.3 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD | 0.8 | 22.6 | 11.9 | 16 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
67.3B HKD | 0.1 | 7 | 1.7 | 2 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.3B CNY | 1.4 | 21.2 | 15.5 | 15.5 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.1B EUR | 3.2 | 45.9 | 14.8 | 29.2 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
50.8B CNY | 0.2 | 13.5 | 8 | 8 | |
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.2 | -5.1 | 3.9 | 19.2 |